Comparison between Infinium Pharmachem IPO and Sancode Technologies IPO.
IPO Details
Infinium Pharmachem IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sancode Technologies IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Infinium Pharmachem IPO is up to ₹23.99 Cr whereas the issue size of the Sancode Technologies IPO is up to ₹4.88 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Sancode Technologies IPO is ₹47.00 per share.
IPO Timetable
Infinium Pharmachem IPO opens on Mar 31, 2023, while Sancode Technologies IPO opens on Mar 31, 2023. The closing date of Infinium Pharmachem IPO and Sancode Technologies IPO is Apr 05, 2023, and Apr 06, 2023, respectively.
| | Infinium Pharmachem IPO | Sancode Technologies IPO |
|---|
| Issue Open | Mar 31, 2023 | Mar 31, 2023 |
| Issue Close | Apr 05, 2023 | Apr 06, 2023 |
| Basis Of Allotment (Tentative) | Apr 11, 2023 | Apr 12, 2023 |
| Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 13, 2023 |
| Credit of Share (Tentative) | Apr 13, 2023 | Apr 17, 2023 |
| Listing date (Tentative) | Apr 17, 2023 | Apr 18, 2023 |
Financials & KPIs
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Sancode Technologies IPO P/E ratio of 10.71.
Shares Offered
In the Infinium Pharmachem IPO Retail Individual Investors (RII) are offered 8,70,000 shares while in Sancode Technologies IPO retail investors are offered 8,70,000 shares. Qualified Institutional Buyers (QIB) are offered in Infinium Pharmachem IPO and in Sancode Technologies IPO.
| | Infinium Pharmachem IPO | Sancode Technologies IPO |
|---|
| Market Maker Reservation | 94,000 shares | 57,000 shares |
| NII | 8,70,000 shares | 5,19,000 shares |
| RII | 8,70,000 shares | 5,19,000 shares |
| Employee | 41,000 shares | |
| Total | 17,81,000 shares | 10,38,000 shares |
Bids Received (Subscription)
Infinium Pharmachem IPO subscribed 1.92x in total, whereas Sancode Technologies IPO subscribed 3.68x.
